Gene · 3872
Papers3,832
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,832
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alveolar-Basal Intermediates Drive Pulmonary Fibrosis via Coordination of a Pro-Fibrotic Signaling Niche in Silicosis. | bioRxiv | 2026 | 41959009 | PubTator, text mining | PubMed |
| Development and Validation of Novel Senescence-TIME Biomarkers for Predicting the Prognosis and Immunotherapy Responsiveness of SKCM Patients. | Int J Med Sci | 2026 | 41938517 | PubTator, text mining | PubMed |
| Immunohistochemical assessment of cytokeratin profile in glandular odontogenic cyst and its comparison with intra-osseous and soft tissue mucoepidermoid carcinoma. | Ann Diagn Pathol | 2026 | 41916182 | PubTator, text mining | PubMed |
| Spatial Distribution of K13-Positive Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis. | Biomedicines | 2026 | 41898372 | PubTator, text mining | PubMed |
| Early Phase Gingival Wound Healing Following Low-Level Er:YAG Laser Irradiation: In Vitro and In Vivo Studies. | Dent J (Basel) | 2026 | 41892746 | PubTator, text mining | PubMed |
| Molecular Markers Distinguishing Early-Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions. | Exp Dermatol | 2026 | 41888970 | PubTator, text mining | PubMed |
| KRT17 promotes triple negative breast cancer through activation of Wnt signaling and γδ T-cells recruitment. | Commun Biol | 2026 | 41888575 | PubTator, text mining | PubMed |
| Keratin as a Potential Prognostic Biomarker for Breast Cancer Progression: An Evidence-Synthesizing Narrative Review. | Breast Cancer (Dove Med Press) | 2026 | 41884419 | PubTator, text mining | PubMed |
| Targeting the epithelium in pulmonary fibrosis. | Eur Respir Rev | 2026 | 41881452 | PubTator, text mining | PubMed |
| Crosstalk between vimentin and keratins in viral infection: Implications across the viral life cycle. | Virulence | 2026 | 41867121 | PubTator, text mining | PubMed |
| Validation of the Workplace COVID-19 Knowledge and Stigma Scale (WoCKSS) in Malaysia: a cross-sectional study using item response theory and factor analyses. | BMJ Open | 2026 | 41857849 | PubTator, text mining | PubMed |
| Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. | Cancer Res | 2026 | 41817415 | PubTator, text mining | PubMed |
| Scar Inhibition in Wound Healing: Mechanisms, Design, and Recent Advances. | Exploration (Beijing) | 2026 | 41810075 | PubTator, text mining | PubMed |
| CRISPR-engineered human lung organoids with a biomolecular condensate reporter enable mechanistic toxicity monitoring. | Mater Today Bio | 2026 | 41809383 | PubTator, text mining | PubMed |
| Targeting the NSUN2-DHODH axis reverses ferroptosis resistance and oxaliplatin resistance in colorectal cancer. | Front Pharmacol | 2026 | 41808866 | PubTator, text mining | PubMed |
| Lactoferrin blocks orthopoxvirus entry via heparan sulphate and regulates host antiviral pathways. | Emerg Microbes Infect | 2026 | 41790953 | PubTator, text mining | PubMed |
| Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review. | Wound Repair Regen | 2026 | 41787822 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| [Crosstalk of keratin 17-positive epithelial cells with CD8+ T cells in oral lichen planus and clinical relevance]. | Zhonghua Kou Qiang Yi Xue Za Zhi | 2026 | 41786518 | PubTator, text mining | PubMed |
| Licoisoflavone B alleviates psoriasis via SCD1-targeted lipid metabolism reprogramming and suppression of Th17/IL-17-mediated inflammation. | Front Pharmacol | 2026 | 41777245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3872/papers?page=3